NAFDAC Alerts Public of Recall of Hydrocortisone 100MG/1 ML Solution

NAFDAC office
Image Credit: © NLIPW

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the Nigerian public about the recall of a batch of Hydrocortisone injection as a precaution following the receipt of a number of complaints that the solution in some ampoules has a yellowish appearance.

HYDROCORTISONEHydrocortisone injection is used to treat symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning).

Hydrocortisone injection is used in the management of multiple sclerosis (a disease in which the nerves do not function properly), lupus (a disease in which the body attacks many of its own organs), gastrointestinal disease, and certain types of arthritis.

It is also used to treat severe allergic reactions and certain conditions that affect the blood, skin, eyes, nervous system, thyroid, kidneys, and lungs.

Hydrocortisone injection is in a class of medications called corticosteroids. It works to treat people with low levels of corticosteroids by replacing steroids that are normally produced naturally by the body. It also works to treat other conditions by reducing swelling and redness and by changing the way the immune system works.

PRODUCT DETAILS

Name of Product: Hydrocortisone Injection
Affected Batch No: 039268
Expiry date: August 2017

HEALTHCARE PROVIDER’S ACTION

Healthcare provider should quarantine any offending ampoules

Print Friendly, PDF & Email
FILE A TRADEMARK
About Bob Aroture 564 Articles
Bob is a Senior Editor and Content Development Manager at Nigerian Law Intellectual Property Watch. He holds a BS degree, with a major in biochemistry. He works directly with the Newsroom Team. His focus areas are technology and innovation, and pharmaceutical technology. Email: editorial@nlipw.com